Latest Commercialisation News

Li-S Energy Limited reported a $6.41 million net loss for FY25 while making significant strides in commercialising its lithium-sulfur battery technology, including commissioning new production facilities and securing key strategic partnerships.

Artrya Limited reported a 17.2% increase in net loss to $16.4 million for FY25, while achieving FDA clearance and launching its AI-driven Salix platform in the U.S. market. The company also secured key commercial partnerships in Australia and raised $20 million in equity funding.

Prescient Therapeutics reported an 11.1% reduction in net loss for FY2025, progressing its lead candidate PTX-100 into Phase 2a trials with FDA Fast Track and Orphan Drug designations, supported by a recent $9.8 million capital raise.

Universal Biosensors Pty Limited has entered voluntary administration with KPMG appointed as administrators, signaling urgent financial distress and a potential restructuring ahead.

Invion Limited secures a pivotal FDA Orphan Drug Designation for its lead candidate INV043, targeting anal cancer with promising preclinical results and a fast-tracked development path.

Papyrus Australia has signed a binding term sheet with TBS Mining Solutions to produce a biodegradable version of the Collar Keeper® product, marking a significant step in commercialising sustainable mining solutions.

Papyrus Australia has signed a binding term sheet with TBS Mining Solutions to produce a biodegradable version of the Collar Keeper®, marking a major step in sustainable mining innovation.

dorsaVi Ltd has unveiled Artemis Labs, a new subsidiary focused on developing advanced AI, sensor, and robotics technologies powered by cutting-edge RRAM. This initiative aims to transform human movement data into intelligent robotic and healthcare applications.

Impact Minerals’ 50%-owned Alluminous Pty Ltd advances its proprietary HiPurA® High Purity Alumina technology with new leadership and pilot plant commissioning, attracting strong customer interest.

Ainsworth Game Technology reported a steady profit before tax of $13.9 million for the first half of 2025, supported by a 25% revenue increase driven by strong North American and Asia Pacific markets.

Wide Open Agriculture has launched a pre-feasibility study for a large-scale lupin protein facility in Western Australia, aiming to establish a new global food category and reduce production costs. This move marks a pivotal step toward commercial scale and global leadership in sustainable plant-based proteins.

AnteoTech has appointed Merrill Gray as its new Managing Director and CEO following a successful interim period, while issuing over 22 million shares to staff under its FY2025 incentive program.